Literature DB >> 26639059

Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned.

Frederick A Zeiler1, Alan C Jackson2.   

Abstract

The Milwaukee protocol has been attributed to survival in rabies encephalitis despite a lack of scientific evidence supporting its therapeutic measures. We have reviewed the literature with reference to specific treatment recommendations made within the protocol. Current literature fails to support an important role for excitotoxicity and cerebral vasospasm in rabies encephalitis. Therapies suggested in the Milwaukee protocol include therapeutic coma, ketamine infusion, amantadine, and the screening/prophylaxis/management of cerebral vasospasm. None of these therapies can be substantiated in rabies or other forms of acute viral encephalitis. Serious concerns over the current protocol recommendations are warranted. The recommendations made by the Milwaukee protocol warrant serious reconsideration before any future use of this failed protocol.

Entities:  

Keywords:  Milwaukee protocol; critical care; infections of the nervous system; infectious diseases; intensive care; neuroprotection; rabies; therapy; virology

Mesh:

Year:  2015        PMID: 26639059     DOI: 10.1017/cjn.2015.331

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  15 in total

Review 1.  Human Rabies: a 2016 Update.

Authors:  Alan C Jackson
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

2.  Case Report: Failure of Therapeutic Coma in Rabies Encephalitis.

Authors:  Abi Manesh; Reeta Subramaniam Mani; Kishore Pichamuthu; Manjeera Jagannati; Vivek Mathew; Rajiv Karthik; Ooriapadickal Cherian Abraham; Geeta Chacko; George M Varghese
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

3.  Lyssavirus phosphoproteins increase mitochondrial complex I activity and levels of reactive oxygen species.

Authors:  Wafa Kammouni; Heidi Wood; Alan C Jackson
Journal:  J Neurovirol       Date:  2017-07-05       Impact factor: 2.643

Review 4.  [Rabies and Bornavirus encephalitis : Fatal emerging viral encephalitis-a potential problem for organ recipients].

Authors:  E Schmutzhard; B Pfausler
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

Review 5.  Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies.

Authors:  Charles Rupprecht; Ivan Kuzmin; Francois Meslin
Journal:  F1000Res       Date:  2017-02-23

6.  Biological Effects and Biodistribution of Bufotenine on Mice.

Authors:  Hugo Vigerelli; Juliana Mozer Sciani; Maria Andrea Camarano Eula; Luciana Almeida Sato; Marta M Antoniazzi; Carlos Jared; Daniel C Pimenta
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

7.  Inhibition of Rabies Virus by 1,2,3,4,6-Penta-O-galloyl-β-d-Glucose Involves mTOR-Dependent Autophagy.

Authors:  Zhongzhong Tu; Wenjie Gong; Yan Zhang; Ye Feng; Yan Liu; Changchun Tu
Journal:  Viruses       Date:  2018-04-17       Impact factor: 5.818

Review 8.  New human rabies vaccines in the pipeline.

Authors:  Anthony R Fooks; Ashley C Banyard; Hildegund C J Ertl
Journal:  Vaccine       Date:  2018-08-25       Impact factor: 3.641

9.  Potential Use of Sofosbuvir in the Prophylaxis for Rabies.

Authors:  Sandra E Reznik; Amit K Tiwari; Charles R Ashby
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

Review 10.  The Imperative of Palliation in the Management of Rabies Encephalomyelitis.

Authors:  Mary Warrell; David A Warrell; Arnaud Tarantola
Journal:  Trop Med Infect Dis       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.